CONFERENCE COVERAGE
American College of Allergy Asthma and Immunology
Annual Meeting
2022 COVERAGE
- Parasitic Infection Common Cause of Persistent Eosinophilia in Inner-City Patients
- Risk of Ischemic Heart Disease Increased in Patients With Asthma
- COVID-19 Vaccine Allergy Program Helps to Overcome Vaccine Hesitancy
- Berotralstat Reduces Real-World Attack Rates in Hereditary Angioedema
- Single-Day Oral Desensitization for Aspirin-Exacerbated Respiratory Disease
- Albuterol/Budesonide Associated With Fewer Asthma Exacerbations
- COVID-19 Vaccine Split-Dosing Proves Safe, Noninferior to Conventional Dosing
- Exacerbation Risk Exists for Patients With All Levels of Asthma Control/Severity
- Use of Biologics Reduces Exacerbations, Emergency Visits in Pediatric Asthma
- Azelastine HCl 0.15% Nasal Spray Rapidly Relieves Seasonal Allergy Symptoms
- Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma
- Researchers Link Smell Loss, Disease Burden, and Dupilumab Efficacy in CRSwNP
Latest Tweets
Follow
@PulmAdvisor
Conference Coverage from
